Rxulti (Brexpiprazole Tablet) 1mg

Rxulti (brexpiprazole) 1mg tablets are an antipsychotic medication used for mood stabilization. This oral treatment supports mental health by balancing neurotransmitters in the brain. Ideal for adults managing symptoms related to schizophrenia and bipolar disorder. Suitable for ambient storage and widely prescribed for mood support.

Strength

1mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

Lundbeck

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rxulti (brexpiprazole) 1mg tablets are commonly prescribed to help stabilize mood in adults with schizophrenia and bipolar disorder. It works within the brain to balance certain neurotransmitters, supporting emotional regulation and reducing symptoms like agitation or mood swings. This medication is often used as part of a broader mental health treatment plan.

Side Effects

Rxulti (brexpiprazole) 1mg tablets may help reduce feelings of restlessness or irritability associated with mood disorders. Some users report improved focus and emotional balance over time. Effects can vary, and it may take several weeks to notice the full benefits of treatment.

Precautions & Warnings

Keep Rxulti (brexpiprazole) 1mg tablets in a cool, dry place away from direct sunlight. Store at room temperature and keep out of reach of children and pets. Do not use if the packaging is damaged or the tablets show signs of tampering. Always follow your healthcare provider’s instructions for safe use.

Avoid Interactions

Rxulti (brexpiprazole) 1mg tablets may interact with alcohol, increasing drowsiness or dizziness. Certain medications, such as strong CYP inhibitors or stimulants, can affect how brexpiprazole works. Always inform your doctor about all prescription and over-the-counter medications you are taking.

Frequently Asked Questions

Rxulti (brexpiprazole) is used to treat symptoms of schizophrenia and bipolar disorder in adults.

Effects may take several weeks to become noticeable as the medication builds in your system.

Alcohol may increase drowsiness or dizziness; it is best to avoid it unless advised otherwise by a healthcare provider.

No, Rxulti (brexpiprazole) is not classified as a controlled substance.

Store Rxulti at room temperature, away from moisture and heat, in a secure location.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.